Trials / Completed
CompletedNCT01368185
Impact of MK-0954A on Uric Acid in the Management of Hypertension (MK-0954A-366)
A Retrospective Survey to Evaluate the Impact of Hyzaar on Uric Acid in the Management of Hypertensive Patients in Normal Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,705 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This was a retrospective, chart review, observational study to assess the effect of MK-0954A (losartan potassium 50 mg + hydrochlorothiazide 12.5 mg \[Hyzaar(R)\]) treatment for a period of at least three months on serum uric acid levels.
Conditions
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2011-06-07
- Last updated
- 2022-02-09
- Results posted
- 2011-09-01
Source: ClinicalTrials.gov record NCT01368185. Inclusion in this directory is not an endorsement.